Cargando…
The Incidence of hypotension with continuous infusion atracurium compared to cisatracurium in the Intensive Care Unit
BACKGROUND: A drug shortage of cisatracurium led to use of atracurium as an alternative neuromuscular blocker (NMB). Cisatracurium may be preferred due to less histamine release and potentially less hypotension. The study purpose is to compare the incidence of hypotension with continuous infusion at...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5479073/ https://www.ncbi.nlm.nih.gov/pubmed/28660165 http://dx.doi.org/10.4103/IJCIIS.IJCIIS_35_16 |
_version_ | 1783245067310333952 |
---|---|
author | VanderWeide, Luke A. Abdel-Rasoul, Mahmoud Gerlach, Anthony Thomas |
author_facet | VanderWeide, Luke A. Abdel-Rasoul, Mahmoud Gerlach, Anthony Thomas |
author_sort | VanderWeide, Luke A. |
collection | PubMed |
description | BACKGROUND: A drug shortage of cisatracurium led to use of atracurium as an alternative neuromuscular blocker (NMB). Cisatracurium may be preferred due to less histamine release and potentially less hypotension. The study purpose is to compare the incidence of hypotension with continuous infusion atracurium to continuous infusion cisatracurium in ICU patients. MATERIALS AND METHODS: This retrospective cohort analysis reviewed 119 ICU patients who received either continuous infusion atracurium (56) or cisatracurium (63). The primary outcome was the incidence of hypotension (mean arterial pressure <60mmHg). Secondary outcomes included: incidence of blood pressure decrease of >20% from baseline, time to first hypotensive episode, treatment for hypotension during NMB use, hospital mortality, ICU and hospital length of stay (LOS), duration of mechanical ventilation (MV), and NMB duration. RESULTS: Hypotension occurred in 64.3% of atracurium patients and 58.7% of cisatracurium patients (P = 0.58), with 60.7% experiencing >20% drop in blood pressure in atracurium group and 54.0% in cisatracurium (P = 0.58). Median time to first hypotensive episode was 9.4[Interquartile range 1.17-19.7] hours atracurium and 4.4[1.5-13.9] hours cisatracurium (P = 0.36). There were no differences between atracurium and cisatracurium groups respectively for median ICU LOS (10.5 days and 12.4 days, P = 0.34), hospital LOS (14.0 days and 17.7 days, P = 0.37), MV duration (9.3 days and 10.5 days, P = 0.43), infusion duration (34.5 hours and 25 hours P = 0.27), or hospital mortality (62.5% and 53.9%, P = 0.336). Hypotension treatment was similar between groups. CONCLUSIONS: The incidence of hypotension was similar between atracurium and cisatracurium. Critical drug shortages may provide an opportunity to study alternative drug therapy. |
format | Online Article Text |
id | pubmed-5479073 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-54790732017-06-28 The Incidence of hypotension with continuous infusion atracurium compared to cisatracurium in the Intensive Care Unit VanderWeide, Luke A. Abdel-Rasoul, Mahmoud Gerlach, Anthony Thomas Int J Crit Illn Inj Sci Original Article BACKGROUND: A drug shortage of cisatracurium led to use of atracurium as an alternative neuromuscular blocker (NMB). Cisatracurium may be preferred due to less histamine release and potentially less hypotension. The study purpose is to compare the incidence of hypotension with continuous infusion atracurium to continuous infusion cisatracurium in ICU patients. MATERIALS AND METHODS: This retrospective cohort analysis reviewed 119 ICU patients who received either continuous infusion atracurium (56) or cisatracurium (63). The primary outcome was the incidence of hypotension (mean arterial pressure <60mmHg). Secondary outcomes included: incidence of blood pressure decrease of >20% from baseline, time to first hypotensive episode, treatment for hypotension during NMB use, hospital mortality, ICU and hospital length of stay (LOS), duration of mechanical ventilation (MV), and NMB duration. RESULTS: Hypotension occurred in 64.3% of atracurium patients and 58.7% of cisatracurium patients (P = 0.58), with 60.7% experiencing >20% drop in blood pressure in atracurium group and 54.0% in cisatracurium (P = 0.58). Median time to first hypotensive episode was 9.4[Interquartile range 1.17-19.7] hours atracurium and 4.4[1.5-13.9] hours cisatracurium (P = 0.36). There were no differences between atracurium and cisatracurium groups respectively for median ICU LOS (10.5 days and 12.4 days, P = 0.34), hospital LOS (14.0 days and 17.7 days, P = 0.37), MV duration (9.3 days and 10.5 days, P = 0.43), infusion duration (34.5 hours and 25 hours P = 0.27), or hospital mortality (62.5% and 53.9%, P = 0.336). Hypotension treatment was similar between groups. CONCLUSIONS: The incidence of hypotension was similar between atracurium and cisatracurium. Critical drug shortages may provide an opportunity to study alternative drug therapy. Medknow Publications & Media Pvt Ltd 2017 /pmc/articles/PMC5479073/ /pubmed/28660165 http://dx.doi.org/10.4103/IJCIIS.IJCIIS_35_16 Text en Copyright: © 2017 International Journal of Critical Illness and Injury Science http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. |
spellingShingle | Original Article VanderWeide, Luke A. Abdel-Rasoul, Mahmoud Gerlach, Anthony Thomas The Incidence of hypotension with continuous infusion atracurium compared to cisatracurium in the Intensive Care Unit |
title | The Incidence of hypotension with continuous infusion atracurium compared to cisatracurium in the Intensive Care Unit |
title_full | The Incidence of hypotension with continuous infusion atracurium compared to cisatracurium in the Intensive Care Unit |
title_fullStr | The Incidence of hypotension with continuous infusion atracurium compared to cisatracurium in the Intensive Care Unit |
title_full_unstemmed | The Incidence of hypotension with continuous infusion atracurium compared to cisatracurium in the Intensive Care Unit |
title_short | The Incidence of hypotension with continuous infusion atracurium compared to cisatracurium in the Intensive Care Unit |
title_sort | incidence of hypotension with continuous infusion atracurium compared to cisatracurium in the intensive care unit |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5479073/ https://www.ncbi.nlm.nih.gov/pubmed/28660165 http://dx.doi.org/10.4103/IJCIIS.IJCIIS_35_16 |
work_keys_str_mv | AT vanderweidelukea theincidenceofhypotensionwithcontinuousinfusionatracuriumcomparedtocisatracuriumintheintensivecareunit AT abdelrasoulmahmoud theincidenceofhypotensionwithcontinuousinfusionatracuriumcomparedtocisatracuriumintheintensivecareunit AT gerlachanthonythomas theincidenceofhypotensionwithcontinuousinfusionatracuriumcomparedtocisatracuriumintheintensivecareunit AT vanderweidelukea incidenceofhypotensionwithcontinuousinfusionatracuriumcomparedtocisatracuriumintheintensivecareunit AT abdelrasoulmahmoud incidenceofhypotensionwithcontinuousinfusionatracuriumcomparedtocisatracuriumintheintensivecareunit AT gerlachanthonythomas incidenceofhypotensionwithcontinuousinfusionatracuriumcomparedtocisatracuriumintheintensivecareunit |